-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:基于2027财年(9月)8.3倍的市盈率,我们将ADNT的12个月目标价下调2美元至24美元,该市盈率较ADNT的历史市盈率存在合理的折让。我们将2026财年的调整后每股收益预期从2.25美元下调至2.15美元,并将2027财年的调整后每股收益预期从3.10美元下调至2.90美元。鉴于ADNT的盈利超出预期并略微上调了2026财年的业绩指引,我们下调了预期和目标价,并维持对该股的“持有”评级。ADNT公布的2026财年第二季度调整后每股收益为0.52美元,高于市场预期的0.69美元(下降25%),远高于市场普遍预期的0.44美元。业绩超预期主要归功于强劲的销售增长,营收增长7%至38.7亿美元(比市场预期高出2.3亿美元),调整后EBITDA利润率下降70个基点至5.8%(符合预期)。我们认为,相比座椅业务,那些在市场高增长领域(例如自动驾驶软件或显示屏)拥有更大份额的汽车供应商更具风险/回报潜力,并且预计未来几个季度利润率压力将持续存在,尤其值得注意的是,其利润率最高的地区(亚洲)正面临最大的挑战。
Related Articles
StarHub's Net Attributable Profit Falls 81% in Q1
StarHub's (SGX:CC3) net attributable profit to shareholders plunged 81% in the first quarter of the year to SG$5.9 million from SG$31.8 million a year earlier, according to a Thursday filing with the Singapore Exchange.Revenue declined 6.1% year over year to SG$507.3 million from SG$540.5 million, mainly due to an across-the-board decline in services revenue.
Meesho Narrows Consolidated Loss in Fiscal Q4
Meesho (NSE:MEESHO, BOM:544632) narrowed its consolidated attributable loss to 1.66 billion Indian rupees in the fiscal fourth quarter ended March 31, from a loss of 13.9 billion rupees a year ago.Loss per share contracted to 0.36 rupees from a loss per share of 3.39 rupees a year earlier, the online marketplace said in a filing to the Indian stock exchanges on Wednesday. The loss per share was lower than the 0.73 rupees estimated by the analysts polled by Visible Alpha.Revenue from operations in fiscal Q4 increased to 35.3 billion rupees from 24.0 billion rupees a year ago. This is a tad higher than Visible Alpha's estimate of 35.2 billion rupees a year ago.
Changchun High-Tech Gets Regulatory Nod for Gouty Arthritis Drug
Changchun High-Tech Industry (SHE:000661) subsidiary Changchun Genescience Pharmaceutical obtained China's regulatory approval to manufacture and market its fuxinqibai monoclonal antibody injection.The drug is indicated for acute gouty arthritis attacks in adults poorly responsive to standard therapies, according to a Thursday filing with the Shenzhen bourse.